Product Information
CAPECITABINE 500 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.4894 per EA under NDC 68001048807. Its NADAC has been published 199 times since Nov 3, 2021.
FDA first approved this application on Apr 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001048807
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
CAPECITABINEApproval Type
Generic (ANDA)
FDA Application
ANDA202593FDA Approved
4/23/2015
TE Code
AB
On Market Since
2/22/2021
Pharmacological Classes
Price Statistics
The NADAC for CAPECITABINE 500 MG TABLET has been published 199 times since Nov 3, 2021, and over the history we have for it it has declined 16.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4894 per EA |
|---|---|
| All-time high | $0.6831 (Oct 12, 2022) |
| All-time low | $0.4342 (Nov 20, 2024) |
| Median price | $0.5479 |
| Average price | $0.5506 |
| Largest weekly change | -21.0% (Feb 21, 2024) |
| Weeks tracked | 199 |
| Tracking since | Nov 3, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-8.5%
5Y
N/A
All
-16.5%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CAPECITABINE 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAPECITABINE 500 MG TABLET, manufactured by BluePoint Laboratories, is $0.4894 per EA (NDC 68001048807), effective Aug 20, 2025.
How has the price of CAPECITABINE 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAPECITABINE 500 MG TABLET has declined 16.5%. It has been tracked across 199 weekly CMS publications since Nov 3, 2021.
What are the highest and lowest recorded NADAC prices for CAPECITABINE 500 MG TABLET?
Since Nov 3, 2021, the NADAC for CAPECITABINE 500 MG TABLET has ranged from a low of $0.4342 (Nov 20, 2024) to a high of $0.6831 (Oct 12, 2022), with a median of $0.5479 per EA.
Are there cheaper alternatives to CAPECITABINE 500 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CAPECITABINE 500 MG TABLET, is $0.4679 per EA — about 4% below CAPECITABINE 500 MG TABLET.
Who manufactures CAPECITABINE 500 MG TABLET?
CAPECITABINE 500 MG TABLET (NDC 68001048807) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.